Pacific Biosciences of California (PACB) Reports Q4 Loss, Misses Revenue Estimates

Pacific Biosciences of California (PACB) came out with a quarterly loss of $0.01 per share versus the Zacks Consensus Estimate of $0.43. This compares to break-even earnings per share a year ago. These figures are adjusted for non-recurring items.Pacific Biosciences of California (PACB) came out with a quarterly loss of $0.01 per share versus the Zacks Consensus Estimate of $0.43. This compares to break-even earnings per share a year ago. These figures are adjusted for non-recurring items.Read MoreStocks,InvestingStocks Feed